EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,044 | -22.4% | 20,118 | +2.0% | 0.00% | – |
| Q4 2022 | $23,267 | -84.4% | 19,718 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $149,000 | +23.1% | 19,790 | +3.2% | 0.00% | 0.0% |
| Q2 2022 | $121,000 | -8.3% | 19,177 | +20.7% | 0.00% | 0.0% |
| Q1 2022 | $132,000 | +50.0% | 15,894 | -6.6% | 0.00% | – |
| Q4 2021 | $88,000 | -24.8% | 17,012 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $117,000 | -23.5% | 17,522 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $153,000 | -3.2% | 17,939 | +0.6% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | -27.9% | 17,829 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $219,000 | +63.4% | 17,781 | +8.1% | 0.00% | 0.0% |
| Q3 2020 | $134,000 | -2.9% | 16,443 | +14.1% | 0.00% | 0.0% |
| Q2 2020 | $138,000 | +46.8% | 14,409 | +3.8% | 0.00% | 0.0% |
| Q1 2020 | $94,000 | -57.1% | 13,877 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $219,000 | +44.1% | 14,678 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $152,000 | -3.8% | 14,802 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $158,000 | +532.0% | 14,905 | +589.7% | 0.00% | – |
| Q1 2017 | $25,000 | +8.7% | 2,161 | +8.6% | 0.00% | – |
| Q4 2016 | $23,000 | -99.9% | 1,990 | -0.3% | 0.00% | – |
| Q3 2016 | $26,726,000 | -32.3% | 1,996 | +0.2% | 0.00% | – |
| Q2 2016 | $39,501,000 | – | 1,993 | +15230.8% | 0.00% | – |
| Q1 2016 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |